Otavio Rocha Fiuza, Barbara Siqueira Souto Maior, Luísa Beisman DE Moraes, Daniel Augusto Xavier Carvalho, João Aléssio Juliano Perfeito, Ernesto Evangelista Neto, André Miotto
{"title":"Assessment of the interval between diagnosis and definitive treatment of lung cancer at a public institution in São Paulo.","authors":"Otavio Rocha Fiuza, Barbara Siqueira Souto Maior, Luísa Beisman DE Moraes, Daniel Augusto Xavier Carvalho, João Aléssio Juliano Perfeito, Ernesto Evangelista Neto, André Miotto","doi":"10.1590/0100-6991e-20253836-en","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>This study aimed to investigate the interval between the diagnosis and definitive surgical treatment of lung cancer patients at a public institution in São Paulo.</p><p><strong>Method: </strong>A retrospective observational study was conducted, using medical records to collect data on the periods between the first abnormal chest computed tomography (CT) scan, the initial consultation with the specialist, and the subsequent tumor resection.</p><p><strong>Results: </strong>The analysis of 20 patients revealed a substantial average waiting period of 425.6 days between diagnosis and definitive treatment. During this interval, an average of 282 days elapsed between diagnosis and the initial specialist consultation, while the period between the first consultation and treatment averaged 143 days. By comparing the initial and final staging, 70% of the patients progressed to a higher stage over this period.</p><p><strong>Conclusions: </strong>The identified interval is concerning and exposes patients to elevated risks during this waiting period. This prolonged duration poses potential threats to patient health, resulting in decreased quality of life, increased risk of disease progression, reduced chances of cure, and diminished overall survival prospects. Addressing and minimizing this extended interval is crucial for improving patient outcomes and enhancing the effectiveness of lung cancer treatment.</p>","PeriodicalId":21454,"journal":{"name":"Revista do Colegio Brasileiro de Cirurgioes","volume":"52 ","pages":"e20253836"},"PeriodicalIF":0.0000,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12401112/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista do Colegio Brasileiro de Cirurgioes","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1590/0100-6991e-20253836-en","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: This study aimed to investigate the interval between the diagnosis and definitive surgical treatment of lung cancer patients at a public institution in São Paulo.
Method: A retrospective observational study was conducted, using medical records to collect data on the periods between the first abnormal chest computed tomography (CT) scan, the initial consultation with the specialist, and the subsequent tumor resection.
Results: The analysis of 20 patients revealed a substantial average waiting period of 425.6 days between diagnosis and definitive treatment. During this interval, an average of 282 days elapsed between diagnosis and the initial specialist consultation, while the period between the first consultation and treatment averaged 143 days. By comparing the initial and final staging, 70% of the patients progressed to a higher stage over this period.
Conclusions: The identified interval is concerning and exposes patients to elevated risks during this waiting period. This prolonged duration poses potential threats to patient health, resulting in decreased quality of life, increased risk of disease progression, reduced chances of cure, and diminished overall survival prospects. Addressing and minimizing this extended interval is crucial for improving patient outcomes and enhancing the effectiveness of lung cancer treatment.
期刊介绍:
History: The publication and dissemination of scientific activities of its members is one of the aims of medical societies. The Brazilian College of Surgeons (Colégio Brasileiro de Cirurgiões – CBC), founded in 1929, already in its first statute provided for the issuance of the “Bulletin of the Brazilian College of Surgeons” as its official division, whose starting number was published in January 1930. In 1967, the National Directory of CBC changed its name to "Journal of the Brazilian College of surgeons", which, however, went on to be published without due regularity. From 1974 on, the journal began to be published bi-monthly, on a regular basis, to the present day. In these more than 40 years of uninterrupted publication, the Journal of the CBC gained importance and scope. With standards and criteria for selection and publication of scientific articles in the area of General and specialist Surgery, including "peer review", the Journal of the CBC falls along the lines of the main international journals and has an Editorial Board that evaluates the merits for publication of submitted manuscripts.